These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1131 related items for PubMed ID: 16541446

  • 1. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.
    Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446
    [Abstract] [Full Text] [Related]

  • 2. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

  • 3. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
    Wexler LH, DeLaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L, Jacobson J, Jarosinski P, Hijazi YM, Balis FM, Horowitz ME.
    Cancer; 1996 Aug 15; 78(4):901-11. PubMed ID: 8756388
    [Abstract] [Full Text] [Related]

  • 4. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM, Cozza R, Ilari I, De Sio L, Boldrini R, Jenkner A, De Ioris M, Inserra A, Dominici C, Donfrancesco A.
    Cancer; 2006 Apr 15; 106(8):1838-45. PubMed ID: 16532434
    [Abstract] [Full Text] [Related]

  • 5. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS.
    N Engl J Med; 2003 Feb 20; 348(8):694-701. PubMed ID: 12594313
    [Abstract] [Full Text] [Related]

  • 6. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.
    J Clin Oncol; 2004 Jul 15; 22(14):2873-6. PubMed ID: 15254055
    [Abstract] [Full Text] [Related]

  • 7. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H, European Intergroup Cooperative Ewing's Sarcoma Study-92.
    J Clin Oncol; 2008 Sep 20; 26(27):4385-93. PubMed ID: 18802150
    [Abstract] [Full Text] [Related]

  • 8. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A.
    Pediatr Blood Cancer; 2007 Aug 20; 49(2):190-5. PubMed ID: 17262797
    [Abstract] [Full Text] [Related]

  • 9. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Krasin MJ, Davidoff AM, Rodriguez-Galindo C, Billups CA, Fuller CE, Neel MD, Merchant TE.
    Cancer; 2005 Jul 15; 104(2):367-73. PubMed ID: 15948159
    [Abstract] [Full Text] [Related]

  • 10. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3838-43. PubMed ID: 16921035
    [Abstract] [Full Text] [Related]

  • 11. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
    Krasin MJ, Rodriguez-Galindo C, Billups CA, Davidoff AM, Neel MD, Merchant TE, Kun LE.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):830-8. PubMed ID: 15465200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
    Kolb EA, Kushner BH, Gorlick R, Laverdiere C, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Wexler L, Wolden S, Meyers PA.
    J Clin Oncol; 2003 Sep 15; 21(18):3423-30. PubMed ID: 12972518
    [Abstract] [Full Text] [Related]

  • 14. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
    La TH, Meyers PA, Wexler LH, Alektiar KM, Healey JH, Laquaglia MP, Boland PJ, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):544-50. PubMed ID: 16198063
    [Abstract] [Full Text] [Related]

  • 15. Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.
    Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS.
    J Clin Oncol; 2003 Aug 01; 21(15):2974-81. PubMed ID: 12885818
    [Abstract] [Full Text] [Related]

  • 16. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, Juergens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht I, Schmelzle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E.
    J Clin Oncol; 2009 Mar 20; 27(9):1446-55. PubMed ID: 19224858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group.
    Bisogno G, Ferrari A, Bergeron C, Scagnellato A, Prete A, Alaggio R, Casanova M, D'Angelo P, Di Cataldo A, Carli M.
    Cancer; 2005 Apr 15; 103(8):1719-24. PubMed ID: 15754335
    [Abstract] [Full Text] [Related]

  • 20. [The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
    Bacci G, Ferrari S, Rosito P, Barbieri E, Mercuri M, Iantorno D, Brach Del Prever A, Ruggieri P, Forni C.
    Minerva Chir; 1997 Apr 15; 52(4):415-26. PubMed ID: 9265127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.